October 11, 2012
Ajinomoto Pharmaceuticals and Astellas Pharma said on October 10 that they have signed an agreement to jointly develop the fast-acting postprandial hypoglycemic agent Fastic/Starsis (nateglinide) for combination treatment with DPP-4 (dipeptidyl peptidase-4) inhibitors. The companies aim to file for the...read more